Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Spirometer Market: By Type, By Technology, By Application, By End User and Region Forecast 2020-2031
Spirometer Market size was valued at US$ 1049.75 million in 2024 and is expected to reach US$ 2111.65 million by 2031, growing at a significant CAGR of 10.5% from 2025-2031. Patients with severe respiratory conditions currently put a heavy burden on healthcare systems around the world, and over the next ten years, this burden is expected to increase. The two primary factors driving the growth of the global market are the rise in the prevalence of chronic pulmonary diseases and the rising R&D expenditure on portable electronics. Spirometry is essential for the diagnosis, monitoring, and management of these patients. Results from spirometry tests are important to medical practitioners since they help with issue diagnosis.
The spirometry is a crucial piece of technology in this regard because it helps determine the severity of the infection and prevents incorrect diagnoses. As a result, it is reasonable to anticipate that the market for spirometer will expand given the rising prevalence of these respiratory disorders. The efficiency of essential bodily organs and functions declines with age. Spirometry results may help in the diagnosis of a number of lung conditions. Spirometry is routinely used to evaluate how well asthma and COPD drugs are functioning, ensuring that patients are getting the most out of their treatment. The COVID-19 outbreak has increased the prevalence of numerous respiratory diseases. In the U.K., therapy for acute exacerbations of CPPD episodes increased over the first six weeks of the COVID-19 pandemic compared to 2019, according to a report published in ERJ Open Research in January 2021.
Study Period
2025-2031Base Year
2024CAGR
10.5%Largest Market
North AmericaFastest Growing Market
North-America
The market will expand quickly as a result of the rise in chronic obstructive pulmonary disease (COPD) prevalence, technological developments in the spirometer industry, and a rising demand for home healthcare. The incidence of chronic obstructive pulmonary disease (COPD), which affects 10.1% of persons globally who are 40 years of age or older, is frequent, preventable, and treatable. With 3.23 million fatalities in 2019, COPD was the third-leading cause of mortality worldwide. The majority of deaths (80%) occurred in low- and middle-income nations. The UN 2030 Agenda for Sustainable Development and the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) both mention COPD.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2024 |
US$ 1049.75 million |
Market Size in 2031 |
US$ 2111.65 million |
Market CAGR |
10.5% |
By Type |
|
By Technology |
|
By Application |
|
By Region |
|
Download Free Sample Report
The spirometer market, valued at US$ 1049.75 million in 2024, is projected to grow at a CAGR of 10.5% from 2025 to 2031.
North-America is the fastest-growing region for market.
Hill-Rom Services, Inc., Fukuda Sangyo Co., Ltd., Chest M.I., Inc., MGC Diagnostics, Vyaire Medical, Inc.
1.Executive Summary |
2.Global Spirometer Market Introduction |
2.1.Global Spirometer Market - Taxonomy |
2.2.Global Spirometer Market - Definitions |
2.2.1. By Type |
2.2.2. By Technology |
2.2.3. By Application |
2.2.4. By Region |
3.Global Spirometer Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Spirometer Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Spirometer Market By Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
5.1. Hand Held |
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Table Top |
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Desktop |
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Spirometer Market By Technology, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
6.1. Volume Measurement |
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Flow Measurement |
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Peak Flow Measurement |
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Spirometer Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
7.1. Asthma |
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. COPD |
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Cystic Fibrosis |
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Pulmonary Fibrosis |
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.Global Spirometer Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Spirometer Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
9.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Hand Held |
9.1.2.Table Top |
9.1.3.Desktop |
9.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Volume Measurement |
9.2.2.Flow Measurement |
9.2.3.Peak Flow Measurement |
9.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Asthma |
9.3.2.COPD |
9.3.3.Cystic Fibrosis |
9.3.4.Pulmonary Fibrosis |
9.3.5.Others |
9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Spirometer Market, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Hand Held |
10.1.2.Table Top |
10.1.3.Desktop |
10.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Volume Measurement |
10.2.2.Flow Measurement |
10.2.3.Peak Flow Measurement |
10.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Asthma |
10.3.2.COPD |
10.3.3.Cystic Fibrosis |
10.3.4.Pulmonary Fibrosis |
10.3.5.Others |
10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Spirometer Market, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Hand Held |
11.1.2.Table Top |
11.1.3.Desktop |
11.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Volume Measurement |
11.2.2.Flow Measurement |
11.2.3.Peak Flow Measurement |
11.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Asthma |
11.3.2.COPD |
11.3.3.Cystic Fibrosis |
11.3.4.Pulmonary Fibrosis |
11.3.5.Others |
11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Spirometer Market, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Hand Held |
12.1.2.Table Top |
12.1.3.Desktop |
12.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Volume Measurement |
12.2.2.Flow Measurement |
12.2.3.Peak Flow Measurement |
12.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Asthma |
12.3.2.COPD |
12.3.3.Cystic Fibrosis |
12.3.4.Pulmonary Fibrosis |
12.3.5.Others |
12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Spirometer Market, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Hand Held |
13.1.2.Table Top |
13.1.3.Desktop |
13.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Volume Measurement |
13.2.2.Flow Measurement |
13.2.3.Peak Flow Measurement |
13.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Asthma |
13.3.2.COPD |
13.3.3.Cystic Fibrosis |
13.3.4.Pulmonary Fibrosis |
13.3.5.Others |
13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.COSMED Srl |
14.2.2.Hill-Rom, Inc. |
14.2.3.MGC Diagnostic Corporation |
14.2.4.Midmark Corporation |
14.2.5.Nspire Health Inc. |
14.2.6.SCHILLER |
14.2.7.Smiths Medical |
14.2.8.Teleflex Incorporated |
14.2.9.Vitalograph |
14.2.10.Vyaire medical |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players